Tissue Regenix U.S. production resumes after cyber attack, shares jump
Share:
(Reuters) - Medical products maker Tissue Regenix Group said on Tuesday its U.S. manufacturing plant had resumed operations following last week's cyber attack on its computer network, sending its shares up as much as 28%.The company said initial investigations found no indications of any external transfer of sensitive or financial data and that costs to restore the systems were not expected to be material to its short-term cash flow.The company took some systems offline early last week after..